Cathepsin C inhibitors
US9187461B2 · kind B2 · utility
0Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2014 |
| Grant date | Nov 17, 2015 |
| Priority date | — |
| Expiry date | Aug 21, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D309/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are 4-amino-2-butenamides of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.